Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
EDITORIAL

Herpes and HIV infection—has the time come to act?

Darren B. Russell
+ Author Affiliations
- Author Affiliations

Cairns Sexual Health Centre, PO Box 902, Cairns, QLD 4870, Australia. Email: darren_russell@health.qld.gov.au

Sexual Health 3(2) 67-71 https://doi.org/10.1071/SH04001
Submitted: 5 January 2004  Accepted: 16 January 2006   Published: 26 May 2006

Abstract

It has been known for some years that the ulcerative and inflammatory STIs lead to an increased risk of HIV transmission. In particular, there is a two- to four-fold increased risk of HIV-1 acquisition associated with prevalent herpes simplex virus type 2. The challenges are discussed herein.


References


[1] Annan K . UNAIDS and World Health Organization Fact Sheet: Sub-Saharan Africa. UNAIDS Epidemic Update 2005. www.who.int/hiv/FS_SubSaharanAfrica_Nov05_en.pdf [verified May 2006].

[2] National Centre in HIV Epidemiology and Clinical Research. 2005 Annual Surveillance Report. p. 5.

[3] UNAIDS. www.unaids.org/en/Regions_Countries/Regions/NthAmer_West_Cent_Europe.asp [verified May 2006].

[4] Fenton AF,  Imrie J. Increasing rates of sexually transmitted diseases in homosexual men in Western Europe and the United States: why? Infect Dis Clin North Am 2005; 19 311–31.
CrossRef | PubMed |

[5] Swearingen SG,  Klausner JD. Sildenafil use, sexual risk behaviour, and risk for sexually transmitted diseases, including HIV infection. Am J Med 2005; 118(6): 571–77.
CrossRef | PubMed |

[6] O’Farrell N. Targeted interventions required against genital ulcers in African countries worst affected by HIV infection. Bull World Health Organ 2001; 79 569–77.
PubMed |

[7] Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19 61–7.
PubMed |

[8] Moss GB,  Overbaugh J,  Welch M,  Reilly M,  Bwayo J,  Plummer FA, et al. Human immunodeficiency virus DNA in urethral secretions in men: association with gonococcal urethritis and CD4 cell depletion. J Infect Dis 1995; 172(6): 1469–74.
PubMed |

[9] Atkins MC,  Carlin EM,  Emery VC,  Griffiths PD,  Boag F. Fluctuations of HIV load in semen of HIV positive patients with newly acquired sexually transmitted diseases. BMJ 1996; 313(7053): 341–2.
PubMed |

[10] Dickerson MC,  Johnston J,  Delea TE,  White A,  Andrews E. The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria. Sex Transm Dis 1996; 23(5): 429–40.
PubMed |

[11] Uter W,  Pfahlberg A. The application of methods to quantify attributable risk in medical practice. Stat Methods Med Res 2001; 10(3): 231–7.
CrossRef | PubMed |

[12] Ghys PD,  Diallo MO,  Ettiegne-Traore V,  Satten GA,  Anoma CK,  Maurice C, et al. Effect of interventions to control sexually transmitted disease on the incidence of HIV infection in female sex workers. AIDS 2001; 15(11): 1421–31.
CrossRef | PubMed |

[13] Grosskurth H,  Gray R,  Hayes R,  Mabey D,  Wawer M. Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet 2000; 355(9219): 1981–7.
CrossRef | PubMed |

[14] Corey L,  Wald A,  Celum CL,  Quinn TC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr 2004; 35(5): 435–45.
PubMed |

[15] Website for ‘ClinicalTrials.gov’. http://www.clinicaltrials.gov/ct/screen/BrowseAny?path=%2Fbrowse%2Fby-sponsor%2FOTHER%2FUniversity%2Bof%2BWashington&recruiting=true [verified April 2006].

[16] Fleming DT,  McQuillan GM,  Johnson RE,  Nahmias AJ,  Aral SO,  Lee FK, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337 1105–11.
CrossRef | PubMed |

[17] Chen CY,  Ballard RC,  Beck-Sague CM,  Dangor Y,  Radebe F,  Schmid S, et al. Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection. Sex Transm Dis 2000; 27 21–9.
PubMed |

[18] Paz-Bailey G,  Rahman M,  Chen C,  Ballard R,  Moffat HJ,  Kenyon T, et al. Changes in the etiology of sexually transmitted diseases in Botswana between 1993 and 2002: implications for the clinical management of genital ulcer disease. Clin Infect Dis 2005; 41(9): 1304–12.
CrossRef | PubMed |

[19] Russell DB,  Tabrizi SN,  Russell JM,  Garland SM. Seroprevalence of herpes simplex virus types 1 and 2 in HIV-infected and uninfected homosexual men in a primary care setting. J Clin Virol 2001; 22 305–13.
CrossRef | PubMed |

[20] Auvert B,  Ballard R,  Campbell C,  Carael M,  Carton M,  Fehler G, et al. HIV infection among youth in a South African mining town is associated with herpes simplex virus-2 seropositivity and sexual behaviour. AIDS 2001; 15(7): 885–98.
CrossRef | PubMed |

[21] Wald A,  Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002; 185 45–52.
CrossRef | PubMed |

[22] Renzi C,  Douglas JM,  Foster M,  Critchlow CW,  Ashley-Morrow R,  Buchbinder SP, et al. Herpes simplex type 2 infection as a risk factor for human immunodeficiency acquisition in men who have sex with men. J Infect Dis 2003; 187 19–25.
CrossRef | PubMed |

[23] Freeman EE,  Glynn JR. Factors affecting HIV concordancy in married couples in four African cities. AIDS 2004; 18 1715–21.
CrossRef | PubMed |

[24] Auvert B,  Buvé A,  Ferry B,  Caraël M,  Morrison L,  Lagarde E, et al. Ecological and individual factor analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection. AIDS 2001; 15(Suppl 4): S15–30.
CrossRef | PubMed |

[25] Blower S,  Ma L. Calculating the contribution of Herpes simplex virus type 2 epidemics to increasing HIV incidence: treatment implications. Clin Infect Dis 2004; 39(Suppl 5): S240–7.
CrossRef | PubMed |

[26] Corey L,  Tyring S,  Patel R,  Sacks SL,  Tyring SK,  Warren T, et al. Once daily valaciclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350 11–20.
CrossRef | PubMed |

[27] World Health Organization. Microbicides. www.who.int/hiv/topics/microbicides/microbicides/en/ [verified April 2006].

[28] Dhawan D,  Mayer KH. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection. J Infect Dis 2006; 193(1): 36–44.
CrossRef | PubMed |

[29] Diamond C,  Richardson JL,  Milam J,  Stoyanoff S,  McCutchan JA,  Kemper C, et al. Use of and adherence to antiretroviral therapy is associated with decreased sexual risk behavior in HIV clinic patients. J Acquir Immune Defic Syndr 2005; 39(2): 211–8.
PubMed |

[30] Bateganya M,  Colfax G,  Shafer LA,  Kityo C,  Mugyenyi P,  Serwadda D, et al. Antiretroviral therapy and sexual behavior: a comparative study between antiretroviral- naive and -experienced patients at an urban HIV/AIDS care and research center in Kampala, Uganda. AIDS Patient Care STDS 2005; 19(11): 760–8.
CrossRef | PubMed |

[31] Bunnell R,  Ekwaru JP,  Solberg P,  Wamai N,  Bikaako-Kajura W,  Were W, et al. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 2006; 20(1): 85–92.
CrossRef | PubMed |

[32] Smith RJ,  Bodine EN,  Wilson DP,  Blower SM. Evaluating the potential impact of vaginal microbicides to reduce the risk of acquiring HIV in female sex workers. AIDS 2005; 19(4): 413–21.
CrossRef | PubMed |

[33] Auvert B , Puren A , Taljaard D , Lagarde E , Sitta R , Tambekou J , et al Impact of male circumcision on the female-to-male transmission of HIV. Program and abstracts of the 3rd IAS Conference on HIV Pathogenesis and Treatment, 24–27 July 2005, Rio de Janeiro, Brazil. Abstract TuOa0402.



Rent Article (via Deepdyve) Export Citation Cited By (2)